↓ Skip to main content

The CD4+/CD14+HLA-DRlo/neg ratio as a prognostic biomarker in cancer patients

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2013
Altmetric Badge

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The CD4+/CD14+HLA-DRlo/neg ratio as a prognostic biomarker in cancer patients
Published in
Journal for Immunotherapy of Cancer, November 2013
DOI 10.1186/2051-1426-1-s1-p50
Authors

Allan B Dietz, Michael P Gustafson, Yi Lin, Betsy LaPlant, Courtney J Liwski, Mary L Maas, Stacy C League, Philippe R Bauer, Roshini S Abraham, Matthew K Tollefson, Eugene D Kwon, Dennis A Gastineau